These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1574609)

  • 1. Chemical characterization of vasoactive intestinal polypeptide-like immunoreactivity in ovine hypothalamus and intestine.
    Miyata A; Jiang L; Stibbs HH; Arimura A
    Regul Pept; 1992 Mar; 38(2):145-54. PubMed ID: 1574609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE; Tatsuno I; Miyata A; Arimura A
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).
    Miyata A; Jiang L; Dahl RD; Kitada C; Kubo K; Fujino M; Minamino N; Arimura A
    Biochem Biophys Res Commun; 1990 Jul; 170(2):643-8. PubMed ID: 2383262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I; Gottschall PE; Arimura A
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
    Shivers BD; Görcs TJ; Gottschall PE; Arimura A
    Endocrinology; 1991 Jun; 128(6):3055-65. PubMed ID: 2036976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut.
    Sundler F; Ekblad E; Absood A; Håkanson R; Köves K; Arimura A
    Neuroscience; 1992; 46(2):439-54. PubMed ID: 1542417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain.
    Köves K; Arimura A; Görcs TG; Somogyvári-Vigh A
    Neuroendocrinology; 1991 Aug; 54(2):159-69. PubMed ID: 1766552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pituitary adenylate cyclase activating polypeptides (PACAPs) specific radioimmunoassay systems and distribution of PACAP-like immunoreactivity in guinea pig tissues.
    Ando E; Nokihara K; Naruse S
    Biomed Pept Proteins Nucleic Acids; 1994-1995; 1(1):45-50. PubMed ID: 9346869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
    D'Agata V; Cavallaro S; Stivala F; Canonico PL
    Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons.
    Tatsuno I; Yada T; Vigh S; Hidaka H; Arimura A
    Endocrinology; 1992 Jul; 131(1):73-81. PubMed ID: 1319331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
    Gourlet P; Woussen-Colle MC; Robberecht P; de Neef P; Cauvin A; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Eur J Biochem; 1991 Jan; 195(2):535-41. PubMed ID: 1997328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus.
    Köves K; Arimura A; Somogyvári-Vigh A; Vigh S; Miller J
    Endocrinology; 1990 Jul; 127(1):264-71. PubMed ID: 2193797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain.
    Suda K; Smith DM; Ghatei MA; Bloom SR
    Neurosci Lett; 1992 Mar; 137(1):19-23. PubMed ID: 1320752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on cyclic AMP accumulation in sheep pituitary cells in vitro.
    Sawangjaroen K; Sernia C; Curlewis JD
    J Endocrinol; 1996 Mar; 148(3):545-52. PubMed ID: 8778233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.